Increase/Decrease in Cash: The total change in cash for the company over the given period.
China SXT Pharmaceuticals, Inc. (SXTC) had Increase/Decrease in Cash of $6.44M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$21.99M |
|
$0.23M |
|
$9.01M |
|
$31.00M |
|
$15.66M |
|
$0.12M |
|
$0.30M |
|
$15.96M |
|
$15.04M |
|
$15.02M |
|
$15.04M |
|
3.91M |
|
| Cash Flow Statement Financials | |
$-1.36M |
|
$0.04M |
|
$7.24M |
|
$12.08M |
|
$18.51M |
|
|
Increase/Decrease in Cash |
$6.44M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|